Nonetheless, considering the possible preparation required to prevent FN such as dose reduction of anti-cancer drugs and prophylactic use of antibiotics and/or G-CSF, the assessment of FN risk before chemotherapy using pretreatment information is thought to be more practical than that after chemotherapy using post-treatment information. The gene discussed is CSF3; the disease is cancer.